<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Surg Neurol Int</journal-id><journal-id journal-id-type="iso-abbrev">Surg Neurol Int</journal-id><journal-id journal-id-type="publisher-id">SNI</journal-id><journal-title-group><journal-title>Surgical Neurology International</journal-title></journal-title-group><issn pub-type="ppub">2229-5097</issn><issn pub-type="epub">2152-7806</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28584678</article-id><article-id pub-id-type="pmc">5445651</article-id><article-id pub-id-type="publisher-id">SNI-8-75</article-id><article-id pub-id-type="doi">10.4103/sni.sni_5_17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Spine: Original Article</subject></subj-group></article-categories><title-group><article-title>Preventive effect of tamsulosin on postoperative urinary retention in neurosurgical patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Basheer</surname><given-names>Azam</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">*</xref><email>abashee1@hfhs.org</email></contrib><contrib contrib-type="author"><name><surname>Alsaidi</surname><given-names>Mohammed</given-names></name><xref ref-type="aff" rid="aff1"/><email>mhka80@gmail.com</email></contrib><contrib contrib-type="author"><name><surname>Schultz</surname><given-names>Lonni</given-names></name><xref ref-type="aff" rid="aff2">1</xref><email>lschult1@hfhs.org</email></contrib><contrib contrib-type="author"><name><surname>Chedid</surname><given-names>Mokbel</given-names></name><xref ref-type="aff" rid="aff1"/><email>mchedid1@hfhs.org</email></contrib><contrib contrib-type="author"><name><surname>Abdulhak</surname><given-names>Muwaffak</given-names></name><xref ref-type="aff" rid="aff1"/><email>mabdulh1@hfhs.org</email></contrib><contrib contrib-type="author"><name><surname>Seyfried</surname><given-names>Donald</given-names></name><xref ref-type="aff" rid="aff1"/><email>dseyfri1@hfhs.org</email></contrib></contrib-group><aff id="aff1">Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan, USA</aff><aff id="aff2"><label>1</label>Department of Public Health Sciences, Henry Ford Hospital, Detroit, Michigan, USA</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author
</corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>10</day><month>5</month><year>2017</year></pub-date><volume>8</volume><elocation-id>75</elocation-id><history><date date-type="received"><day>04</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>02</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2017 Surgical Neurology International</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Postoperative urinary retention (POUR) is common in neurosurgical patients. The use of alpha-blockade therapy, such as tamsulosin, has benefited many patients with a history of obstructive uropathy by decreasing lower urinary tract symptoms such as distension, infections, and stricture formation, as well as the incidence of POUR. For this study, we targeted patients who had undergone spinal surgery to examine the prophylactic effects of tamsulosin. Increased understanding of this therapy will assist in minimizing the morbidity of spinal surgery.</p></sec><sec id="st2"><title>Methods:</title><p>We enrolled 95 male patients undergoing spine surgery in a double-blind, randomized, placebo-controlled trial. Patients were randomly assigned to receive either preoperative tamsulosin (N = 49) or a placebo (N = 46) and then followed-up prospectively for the development of POUR after removal of an indwelling urinary catheter (IUC). They were also followed-up for the incidence of IUC reinsertions.</p></sec><sec id="st3"><title>Results:</title><p>The rate of developing POUR was similar in both the groups. Of the 49 patients given tamsulosin, 16 (36%) developed POUR compared to 13 (28%) from the control group (<italic>P</italic> = 0.455). In the control group, 5 (11%) patients had IUC re-inserted postoperatively, whereas 7 (14%) patients in the tamsulosin group had IUC re-inserted postoperatively (<italic>P</italic> = 0.616). In patients suffering from axial-type symptoms (i.e., mechanical back pain), 63% who received tamsulosin and 18% from the control group (<italic>P</italic> = 0.048) developed POUR.</p></sec><sec id="st4"><title>Conclusion:</title><p>Overall, there was no statistically significant difference in the rates of developing POUR among patients in either group. POUR is caused by a variety of factors, and further studies are needed to shed light on its etiology.</p></sec></abstract><kwd-group><kwd>Adrenergic alpha-antagonists</kwd><kwd>indwelling urinary catheter</kwd><kwd>neurosurgery</kwd><kwd>postoperative urinary retention</kwd><kwd>tamsulosin</kwd><kwd>urinary retention</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Postoperative urinary retention (POUR) has been defined as the inability to void despite a full bladder.[<xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref25" ref-type="bibr">25</xref>] Catheterization can cause significant pain, bladder discomfort, anxiety, and increased cost, resulting in prolonged hospital stays.[<xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref30" ref-type="bibr">30</xref>] It has been reported that a single significant episode of bladder distention can lead to weakened bladder collagen fibers, resulting in chronic impairment of bladder emptying capacity or even atony.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref6" ref-type="bibr">6</xref>]</p><p>Advances in pharmacology, specifically the institution of selective alpha-blockers (e.g., tamsulosin), have provided feasible, noninvasive interventions in the treatment of benign prostatic hyperplasia (BPH).[<xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref31" ref-type="bibr">31</xref>] In our clinical experience, male patients undergoing spinal surgery, regardless of age, have a significant incidence of POUR, resulting in delayed discharge from the hospital and additional testing and procedures.</p><p>The purpose of our study was to determine if pharmacological intervention using tamsulosin, administered perioperatively, would reduce the incidence of POUR in men undergoing elective spinal surgery.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><sec id="sec2-1"><title>Study design and participants</title><p>This was a double-blind, randomized, placebo-controlled trial carried out from April 2012 to January 2013. Ninety-five male neurosurgical patients undergoing spine surgery in our hospital were randomly assigned to receive preoperative tamsulosin (Flomax&#x000ae;) and then followed up prospectively for the development of POUR. This study was approved by the Henry Ford Hospital Institutional Review Board (IRB # 6893).</p><p>The study was introduced to eligible male patients between the ages of 18 and 80 who presented to the Neurosurgery Department Clinic of Henry Ford Hospital for elective spinal surgery. Patients were excluded from the study if they met any of the criteria in <xref ref-type="table" rid="T1">Table 1</xref>. Our rationale for enrolling male patients only was that tamsulosin has been approved by the Food and Drug Administration (FDA) for use in male patients as it exerts its therapeutic effects by relaxing the smooth muscles in the prostate. Furthermore, diagnosed or undiagnosed BPH could be a contributing cause in relatively high-risk males.[<xref rid="ref23" ref-type="bibr">23</xref>] Those with a creatinine level &#x0003e;2.5 were excluded. Tamsulosin is metabolized mainly via the liver, therefore, liver function was also assessed. All participants underwent ultrasonographic investigation or bladder scanning in the clinic to measure residual urine [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Inclusion and exclusion criteria used for patients enrolled in the study</p></caption><graphic xlink:href="SNI-8-75-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Demographic and past medical history information</p></caption><graphic xlink:href="SNI-8-75-g002"/></table-wrap></sec><sec id="sec2-2"><title>Randomization, masking, and data collection</title><p>Patients who enrolled were then randomly assigned to either tamsulosin or placebo pills using a computer-generated randomization list, which was stratified by age (&#x0003c;50, 50&#x02013;64, and 65+ years). Patients and study assessors were masked to the treatment allocation. Medication (0.4 mg of tamsulosin or placebo) was administered orally 48 h before the surgery and the night before surgery. On the day of the surgery, patients were monitored by the project team while in hospital as well as upon discharge. The amount of postoperative urinary volume was monitored using the standard bladder ultrasound until post-void residual of &#x0003c; 250 ml was reached. Patients were continued on medication/placebo every night while inpatient until the Foley placed during surgery was removed, typically on postoperative day 1. Medication/placebo was discontinued if no Foley was placed during surgery. No patients were sent home on the medication/placebo postoperatively. In all cases, intravenous fluids were administered in the operating room before the anesthetic was given and continued postoperatively until the day after surgery (12&#x02013;18 h).</p><p>Patients were placed on a pain-control pump (PCA) of either morphine or Dilaudid postoperatively and subsequently weaned to oral narcotics on postoperative day 1. Patients&#x02019; charts were reviewed and total narcotics dosage and benzodiazepine doses were calculated. All patients were followed during their postoperative stay for any voiding difficulties, and urinary retention was recorded.</p></sec><sec id="sec2-3"><title>Definition of postoperative urinary retention</title><p>POUR, as per the hospital protocol, was defined as an initial post-void residual (PVR) greater than 250 ml using bladder ultrasonography (BVI 3000, Verathon) 6 h after the removal of IUCs inserted during surgery. Straight catheterization was performed for patients with PVR greater than 250 ml every 6 h. For patients with the third PVR greater than 250 ml, IUCs were reinserted. Patients were then discharged and instructed to return to the urology clinic in 5&#x02013;7 days for follow-up. Subsequently, patients&#x02019; records were reviewed for multiple variables [Tables <xref ref-type="table" rid="T3">3</xref>&#x02013;<xref ref-type="table" rid="T5">5</xref>]. The total amount of narcotic use was calculated and converted into morphine equianalgesic dose (MED). Total benzodiazepine intake was collected and also considered in our analyses.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Data collected from patients during surgery and hospitalization</p></caption><graphic xlink:href="SNI-8-75-g003"/></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Presurgical clinical data collected from all study patients</p></caption><graphic xlink:href="SNI-8-75-g004"/></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Subgroup statistical analysis comparing POUR with several variables between the tamsulosin and placebo groups</p></caption><graphic xlink:href="SNI-8-75-g005"/></table-wrap></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>The incidence of POUR in all patients was 32% (i.e., based on our definition of first PVR greater than 250 ml). The rate of developing POUR was similar in the placebo and treatment groups, with 16 patients (36%) in the tamsulosin group developing POUR compared to 13 patients (28%) from the placebo group (<italic>P</italic> = 0.455). The rates of Foley reinsertion were also comparable for the two treatment groups (14% for tamsulosin vs 11% for placebo, <italic>P</italic> = 0.616). No differences were observed between the two groups for length of stay (LOS) (<italic>P</italic> = 0.755) and discharge disposition (<italic>P</italic> = 0.394). For those with predominantly axial back pain, using tamsulosin postoperatively resulted in POUR in 63% versus 18% of patients receiving placebo (<italic>P</italic> = 0.048).</p></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>POUR is a well-established and commonly encountered problem across all surgical specialties (frequency of 5% to 75%), but has not been studied extensively in spinal neurosurgical patients.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref13" ref-type="bibr">13</xref>] Boulis <italic>et al</italic>. reported a 39.1% incidence or POUR in 503 spine patients.[<xref rid="ref5" ref-type="bibr">5</xref>] McLain <italic>et al</italic>. and Jellish <italic>et al</italic>. reported a 23% and 22.9% incidence of POUR, respectively, in lumbar spine surgery.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref17" ref-type="bibr">17</xref>] In our previous study, the overall incidence of POUR after spine surgery was 39.4%.[<xref rid="ref2" ref-type="bibr">2</xref>] Many factors may contribute to POUR, including old age, male gender, and preexisting urologic symptoms to be associated with the development of POUR.[<xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref25" ref-type="bibr">25</xref><xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr">29</xref>] Certain medications, such as beta blockers and anticholinergic agents, also contribute to POUR.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref6" ref-type="bibr">6</xref>] In our study, only male gender and spine surgery were strongly linked to POUR.</p><p>Tamsulosin was first developed in Japan and marketed in 1996 under the trade name Flomax&#x000ae;.[<xref rid="ref23" ref-type="bibr">23</xref>] It is a potent selective alpha-1 receptor antagonist. Specifically, it has preferential selectivity for the alpha-1A adrenergic antagonist (&#x003b1;1A) receptor in the prostate versus the alpha-1B adrenergic antagonist (&#x003b1;1B) receptor in the blood vessels.[<xref rid="ref14" ref-type="bibr">14</xref>] It decreases the peristaltic movements in the ureter, the amplitude of detrusor contractions, the urethral opening pressure, and the frequency of micturition. Studies have validated its effectiveness in the symptomatic treatment of BPH.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref19" ref-type="bibr">19</xref>] By selectively binding to the alpha-1A receptors in the bladder neck and the prostate, it causes relaxation of the smooth musculature, which in turn results in less resistance to urinary flow.</p><p>We are aware of only four randomized trials that assessed the effectiveness of tamsulosin administered perioperatively to prevent POUR, however, none involved spine surgery.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref18" ref-type="bibr">18</xref><xref rid="ref20" ref-type="bibr">20</xref>] Mohammadi-Fallah <italic>et al</italic>. followed 80 males who underwent elective inguinal herniorrhaphy.[<xref rid="ref18" ref-type="bibr">18</xref>] Patients were randomly assigned to receive two doses of placebo orally, 6 h before surgery and 6 to 12 h after surgery (controls), versus the treatment group who received 0.4 mg tamsulosin orally; 15% of the patients in the control group developed POUR compared to only 2.5% in the treatment group (<italic>P</italic> = 0.04).[<xref rid="ref18" ref-type="bibr">18</xref>]</p><p>Madani <italic>et al</italic>. followed 232 male patients aged 18 to 50 years of age undergoing varicocelectomy, inguinal herniorrhaphy, and scrotal surgery.[<xref rid="ref16" ref-type="bibr">16</xref>] They were randomized to receive either three doses of 0.4 mg tamsulosin (<italic>N</italic> = 118) or placebo (<italic>N</italic> = 114). POUR developed in 5.9% of the patients receiving tamsulosin versus 21.1% for control patients (<italic>P</italic> = 0.001). Ahmad <italic>et al</italic>. studied 626 patients undergoing benign anorectal conditions; 313 patients received tamsulosin and 313 received placebo/controls.[<xref rid="ref25" ref-type="bibr">25</xref>] Of the control group, 56 (17.9%) developed POUR compared to 8 (2.5%) patients from the tamsulosin group. In the fourth study, Jang <italic>et al</italic>. found that tamsulosin had no effect on the rate of POUR.[<xref rid="ref19" ref-type="bibr">19</xref>] There were 94 patients with rectal cancer who were randomly assigned to tamsulosin (0.2 mg/day orally for 7 days) (<italic>N</italic> = 47) or the control group (<italic>N</italic> = 47); POUR occurred in 23.4 vs. 21.3 %, respectively; <italic>P</italic> = 0.804).</p><p>The etiology of urinary retention following spine surgery is likely neurological manipulation.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref15" ref-type="bibr">15</xref>] Although the benefits of tamsulosin therapy have been demonstrated in those with BPH, there have been no studies to demonstrate the efficacy of this therapy for urinary retention in the neurosurgical patient. Nevertheless, many patients without underlying BPH may benefit from alpha-blockage, particularly those who have had manipulation of the neurogenic supply to the bladder and urethra secondary to recent spinal surgery. Studies have shown that male gender, preoperative urinary symptoms, diabetes mellitus, large amounts of intravenous fluid administered perioperatively, and postoperative pain are independent risk factors for POUR.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref29" ref-type="bibr">29</xref>]</p><p>We previously found a trend of increased retention following cervicothoracic surgeries compared with lumbar surgeries, which may be due to damaged spinal cord fibers, however, the type of surgery had little to no bearing on the development of POUR in the tamsulosin and placebo groups.[<xref rid="ref2" ref-type="bibr">2</xref>] In addition, longer LOS is positively correlated with POUR.[<xref rid="ref4" ref-type="bibr">4</xref>] Balderi <italic>et al</italic>. found that patients who developed POUR had a median LOS of 7 days compared with 6 days without POUR (<italic>P</italic> = 0.007).[<xref rid="ref4" ref-type="bibr">4</xref>] In this study, patients with POUR had significantly longer LOS compared to those without (4.1 vs. 2.5 days, <italic>P</italic> = 0.018). However, we found no statistically significant difference in LOS between those receiving perioperative tamsulosin and those receiving placebo (3.5 vs. 2.8 days, <italic>P</italic> = 0.755). This was expected as the rate of developing POUR was similar in both groups.</p><p>Finally, it is widely believed that the use of pain medications contributes to the development of POUR.[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref19" ref-type="bibr">19</xref>] This was not the case in our study as there was no difference in the amount of narcotic analgesics used by both groups. Not only did patients have similar use of narcotics (<italic>P</italic> = 0.93) but they also had similar pain scores (<italic>P</italic> = 0.73). Thus, narcotic use had no bearing on the incidence of POUR.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Despite largely negative study results, tamsulosin has shown promise when used in other specialties as well as positive trends in certain patient subgroups. Further and larger clinical trials are needed to investigate the effectiveness of such medications in patients undergoing spinal surgery.</p><sec id="sec2-4"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-5" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><fn-group><fn fn-type="other"><p><ext-link ext-link-type="uri" xlink:href="http://surgicalneurologyint.com/Preventive-effect-of-tamsulosin-on-postoperative-urinary-retention-in-neurosurgical-patients/">http://surgicalneurologyint.com/Preventive-effect-of-tamsulosin-on-postoperative-urinary-retention-in-neurosurgical-patients/</ext-link></p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>MM</given-names></name><name><surname>Wani</surname><given-names>HA</given-names></name><name><surname>Jeelani</surname><given-names>A</given-names></name><name><surname>Thakur</surname><given-names>S</given-names></name><name><surname>Waseem</surname><given-names>M</given-names></name><name><surname>Nazir</surname><given-names>I</given-names></name></person-group><article-title>Preventive effect of tamsulosin on postoperative urinary retention in benign anorectal surgeries</article-title><source>Saudi Surg J</source><year>2014</year><volume>2</volume><fpage>33</fpage><lpage>7</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsaidi</surname><given-names>M</given-names></name><name><surname>Guanio</surname><given-names>J</given-names></name><name><surname>Basheer</surname><given-names>A</given-names></name><name><surname>Schultz</surname><given-names>L</given-names></name><name><surname>Adulhak</surname><given-names>M</given-names></name><name><surname>Nerenz</surname><given-names>D</given-names></name><etal/></person-group><article-title>The incidence and risk factors for postoperative urinary retention in neurosurgical patients</article-title><source>Surg Neurol Int</source><year>2013</year><volume>4</volume><fpage>61</fpage><pub-id pub-id-type="pmid">23772331</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balderi</surname><given-names>T</given-names></name><name><surname>Mistraletti</surname><given-names>G</given-names></name><name><surname>D&#x02019;Angelo</surname><given-names>E</given-names></name><name><surname>Carli</surname><given-names>F</given-names></name></person-group><article-title>Incidence of postoperative urinary retention (POUR) after joint arthroplasty and management using ultrasound-guided bladder catheterization</article-title><source>Minerva Anestesiol</source><year>2011</year><volume>77</volume><fpage>1050</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21597444</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldini</surname><given-names>G</given-names></name><name><surname>Bagry</surname><given-names>H</given-names></name><name><surname>Aprikian</surname><given-names>A</given-names></name><name><surname>Carli</surname><given-names>F</given-names></name></person-group><article-title>Postoperative urinary retention anesthetic and perioperative considerations</article-title><source>Anesthesiology</source><year>2009</year><volume>110</volume><fpage>1139</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">19352147</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulis</surname><given-names>NM</given-names></name><name><surname>Mian</surname><given-names>FS</given-names></name><name><surname>Rodriguez</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Hoff</surname><given-names>JT</given-names></name></person-group><article-title>Urinary retention following routine neurosurgical spine procedures</article-title><source>Surg Neurol</source><year>2001</year><volume>55</volume><fpage>23</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11248301</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darrah</surname><given-names>DM</given-names></name><name><surname>Griebling</surname><given-names>TL</given-names></name><name><surname>Silverstein</surname><given-names>JH</given-names></name></person-group><article-title>Postoperative urinary retention</article-title><source>Anesthesiol Clin</source><year>2009</year><volume>27</volume><fpage>465</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">19825487</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Getliffe</surname><given-names>K</given-names></name></person-group><article-title>Care of urinary catheters</article-title><source>Nurs Stand</source><year>1996</year><volume>11</volume><fpage>47</fpage><lpage>50</lpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haley</surname><given-names>RW</given-names></name><name><surname>Hooton</surname><given-names>TM</given-names></name><name><surname>Culver</surname><given-names>DH</given-names></name><name><surname>Stanley</surname><given-names>RC</given-names></name><name><surname>Emori</surname><given-names>TG</given-names></name><name><surname>Hardison</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Nosocomial infections in U.S. hospitals, 1975-1976; Estimated frequency by selected characteristics of patients</article-title><source>Am J Med</source><year>1981</year><volume>70</volume><fpage>947</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">6938129</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>JH</given-names></name><name><surname>Kang</surname><given-names>SB</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Ahn</surname><given-names>S</given-names></name></person-group><article-title>Randomized controlled trial of tamsulosin for prevention of acute voiding difficulty after rectal cancer surgery</article-title><source>World J Surg</source><year>2012</year><volume>36</volume><fpage>2730</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22806208</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jellish</surname><given-names>WS</given-names></name><name><surname>Thalji</surname><given-names>Z</given-names></name><name><surname>Stevenson</surname><given-names>K</given-names></name><name><surname>Shea</surname><given-names>J</given-names></name></person-group><article-title>A prospective randomized study comparing short- and intermediate-term perioperative outcome variables after spinal or general anesthesia for lumbar disk and laminectomy surgery</article-title><source>Anesth Analg</source><year>1996</year><volume>83</volume><fpage>559</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">8780281</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kebapci</surname><given-names>N</given-names></name><name><surname>Yenilmez</surname><given-names>A</given-names></name><name><surname>Efe</surname><given-names>B</given-names></name><name><surname>Entok</surname><given-names>E</given-names></name><name><surname>Demirustu</surname><given-names>C</given-names></name></person-group><article-title>Bladder dysfunction in type 2 diabetic patients</article-title><source>Neurourol Urodyn</source><year>2007</year><volume>26</volume><fpage>814</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17455274</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keita</surname><given-names>H</given-names></name><name><surname>Diouf</surname><given-names>E</given-names></name><name><surname>Tubach</surname><given-names>F</given-names></name><name><surname>Brouwer</surname><given-names>T</given-names></name><name><surname>Dahmani</surname><given-names>S</given-names></name><name><surname>Mantz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Predictive factors of early postoperative urinary retention in the postanesthesia care unit</article-title><source>Anesth Analg</source><year>2005</year><volume>101</volume><fpage>592</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16037182</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kneist</surname><given-names>W</given-names></name><name><surname>Junginger</surname><given-names>T</given-names></name></person-group><article-title>Long-term urinary dysfunction after mesorectal excision: A prospective study with intraoperative electrophysiological confirmation of nerve preservation</article-title><source>Eur J Surg Oncol</source><year>2007</year><volume>33</volume><fpage>1068</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">17524598</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Lim</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Choi</surname><given-names>HJ</given-names></name><name><surname>Noh</surname><given-names>DH</given-names></name><name><surname>Lee</surname><given-names>HW</given-names></name><etal/></person-group><article-title>Predictors of successful trial without catheter for postoperative urinary retention following non-urological surgery</article-title><source>Int Neurourol J</source><year>2011</year><volume>15</volume><fpage>158</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">22087425</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>CC</given-names></name><name><surname>Lee</surname><given-names>CL</given-names></name><name><surname>Chang</surname><given-names>TC</given-names></name><name><surname>Chang</surname><given-names>YL</given-names></name><name><surname>Wang</surname><given-names>CJ</given-names></name><name><surname>Soong</surname><given-names>YK</given-names></name></person-group><article-title>Postoperative urinary outcomes in catheterized and non-catheterized patients undergoing laparoscopic-assisted vaginal hysterectomy &#x02013; A randomized controlled trial</article-title><source>Int Urogynecol J</source><year>2009</year><volume>20</volume><fpage>295</fpage><lpage>300</lpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madani</surname><given-names>A</given-names></name><name><surname>Aval</surname><given-names>H</given-names></name><name><surname>Mokhtari</surname><given-names>G</given-names></name><name><surname>Nasseh</surname><given-names>H</given-names></name><name><surname>Esmaeili</surname><given-names>S</given-names></name><name><surname>Shakiba</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effectiveness of tamsulosin in prevention of post-operative urinary retention: A randomized double-blind placebo-controlled study</article-title><source>Int Braz J Urol</source><year>2014</year><volume>40</volume><fpage>30</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">24642148</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLain</surname><given-names>RF</given-names></name><name><surname>Kalfas</surname><given-names>I</given-names></name><name><surname>Bell</surname><given-names>GR</given-names></name><name><surname>Tetzlaff</surname><given-names>JE</given-names></name><name><surname>Yoon</surname><given-names>HJ</given-names></name><name><surname>Rana</surname><given-names>M</given-names></name></person-group><article-title>Comparison of spinal and general anesthesia in lumbar laminectomy surgery: A case-controlled analysis of 400 patients</article-title><source>J Neurosurg Spine</source><year>2005</year><volume>2</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15658121</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi-Fallah</surname><given-names>M</given-names></name><name><surname>Hamedanchi</surname><given-names>S</given-names></name><name><surname>Tayyebi-Azar</surname><given-names>A</given-names></name></person-group><article-title>Preventive effect of tamsulosin on postoperative urinary retention</article-title><source>Korean J Urol</source><year>2012</year><volume>53</volume><fpage>419</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">22741052</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>S</given-names></name><name><surname>Nielsen</surname><given-names>J</given-names></name></person-group><article-title>A study into postoperative urine retention in the recovery ward</article-title><source>Br J Anaesth Recov Nurs</source><year>2007</year><volume>8</volume><fpage>91</fpage><lpage>5</lpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petros</surname><given-names>JG</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Robillard</surname><given-names>RJ</given-names></name><name><surname>Argy</surname><given-names>O</given-names></name></person-group><article-title>Factors influencing postoperative urinary retention in patients undergoing elective inguinal herniorrhaphy</article-title><source>Am J Surg</source><year>1991</year><volume>161</volume><fpage>431</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">2035761</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petros</surname><given-names>JG</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Robillard</surname><given-names>R</given-names></name></person-group><article-title>Factors influencing urinary tract retention after elective open cholecystectomy</article-title><source>Surg Gynecol Obstet</source><year>1992</year><volume>174</volume><fpage>497</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">1350689</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platt</surname><given-names>R</given-names></name><name><surname>Polk</surname><given-names>BF</given-names></name><name><surname>Murdock</surname><given-names>B</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name></person-group><article-title>Mortality associated with nosocomial urinary-tract infection</article-title><source>N Engl J Med</source><year>1982</year><volume>307</volume><fpage>637</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">7110215</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roehrborn</surname><given-names>CG</given-names></name><name><surname>Siami</surname><given-names>P</given-names></name><name><surname>Barkin</surname><given-names>J</given-names></name><name><surname>Damiao</surname><given-names>R</given-names></name><name><surname>Major-Walker</surname><given-names>K</given-names></name><name><surname>Morrill</surname><given-names>B</given-names></name><etal/></person-group><article-title>The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study</article-title><source>J Urol</source><year>2008</year><volume>179</volume><fpage>616</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">18082216</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaeffer</surname><given-names>AJ</given-names></name></person-group><article-title>Catheter-associated bacteriuria</article-title><source>Urol Clin North Am</source><year>1986</year><volume>13</volume><fpage>735</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">3535214</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siroky</surname><given-names>M</given-names></name></person-group><article-title>The aging bladder</article-title><source>Rev Urol</source><year>2004</year><volume>6</volume><fpage>S3</fpage><lpage>7</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>NK</given-names></name><name><surname>Albazzaz</surname><given-names>MK</given-names></name></person-group><article-title>A prospective study of urinary retention and risk of death after proximal femoral fracture</article-title><source>Age Ageing</source><year>1996</year><volume>25</volume><fpage>150</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8670545</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>NM</given-names></name><name><surname>Sutter</surname><given-names>VL</given-names></name><name><surname>Mims</surname><given-names>MM</given-names></name><name><surname>Marsh</surname><given-names>VH</given-names></name><name><surname>Finegold</surname><given-names>SM</given-names></name></person-group><article-title>Clinical aspects of bacteremia after manipulation of the genitourinary tract</article-title><source>J Infect Dis</source><year>1973</year><volume>127</volume><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">4683102</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tehranchi</surname><given-names>A</given-names></name><name><surname>Rezaei</surname><given-names>Y</given-names></name><name><surname>Shojaee</surname><given-names>R</given-names></name></person-group><article-title>Tolterodine to relieve urinary symptoms following transurethral resection of the prostate: A double-blind placebo-controlled randomized clinical trial</article-title><source>Korean J Urol</source><year>2014</year><volume>55</volume><fpage>260</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">24741415</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyonaga</surname><given-names>T</given-names></name><name><surname>Matsushima</surname><given-names>M</given-names></name><name><surname>Sogawa</surname><given-names>N</given-names></name><name><surname>Jiang</surname><given-names>SF</given-names></name><name><surname>Matsumura</surname><given-names>N</given-names></name><name><surname>Shimojima</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Postoperative urinary retention after surgery for benign anorectal disease: Potential risk factors and strategy for prevention</article-title><source>Int J Colorectal Dis</source><year>2006</year><volume>21</volume><fpage>676</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">16552523</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>JW</given-names></name><name><surname>Platt</surname><given-names>R</given-names></name><name><surname>Thomas</surname><given-names>RJ</given-names></name></person-group><article-title>Antibiotic irrigation and catheter-associated urinary-tract infections</article-title><source>N Engl J Med</source><year>1978</year><volume>299</volume><fpage>570</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">210379</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>MP</given-names></name><name><surname>Wallhagen</surname><given-names>M</given-names></name><name><surname>Dowling</surname><given-names>G</given-names></name></person-group><article-title>Urinary retention in hospitalized elderly women</article-title><source>J Gerontol Nurs</source><year>1993</year><volume>19</volume><fpage>7</fpage><lpage>14</lpage></element-citation></ref></ref-list></back></article>